•
Mar 31, 2021

Summit Therapeutics Q1 2021 Earnings Report

Total Revenue
$192K
Previous year: $315K
-39.0%
EPS
-$0.21
Previous year: -$0.02
+950.0%
Gross Profit
$192K
Previous year: $386K
-50.3%
Cash and Equivalents
$102M
Previous year: $54.9M
+86.0%
Free Cash Flow
-$20.7M
Previous year: -$4.99M
+315.1%
Total Assets
$141M

Summit Therapeutics

Summit Therapeutics